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Abstract
Background: Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder that can
negatively impact on an individual’s quality of life. It is pathophysiologically complex and heterogeneous with
different neuropsychological processes being impaired in different individuals. Executive function deficits, including
those affecting attention, working memory and inhibitory control, are common. Cognitive training has been promoted
as a treatment option, based on the notion that by strengthening the neurocognitive networks underlying these
executive processes, ADHD symptoms will also be reduced. However, if implemented in childhood or later, when the
full disorder has become well-established, cognitive training has only limited value. INTERSTAARS is a trial designed to
test a novel approach to intervention, in which cognitive training is implemented early in development, before the
emergence of the disorder. The aim of INTERSTAARS is to train early executive skills, thereby increasing resilience and
reducing later ADHD symptoms and associated impairment.
Methods/design: Fifty 10–14-month-old infants at familial risk of ADHD will participate in INTERSTAARS. Infants
will be randomised to an intervention or a control group. The intervention aims to train early attention skills
by using novel eye-tracking technology and gaze-contingent training paradigms. Infants view animated games
on a screen and different events take place contingent on where on the screen the infant is looking. Infants
allocated to the intervention will receive nine weekly home-based attention training sessions. Control group
infants will also receive nine weekly home visits, but instead of viewing the training games during these visits
they will view non-gaze-contingent age-appropriate videos. At baseline and post treatment, infant attention
control will be assessed using a range of eye-tracking, observational, parent-report and neurophysiological
measures. The primary outcome will be a composite of eye-tracking tasks used to assess infant attention skills.
Follow-up data will be collected on emerging ADHD symptoms when the infants are 2 and 3 years old.
Discussion: This is the first randomised controlled trial to assess the potential efficacy of cognitive training as
a prevention measure for infants at familial risk of ADHD. If successful, INTERSTAARS could offer a promising
new approach for developing early interventions for ADHD.
Trial registration: International Standard Randomised Controlled Trial registry: ISRCTN37683928. Registered on
22 June 2015.
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Background
Attention deficit hyperactivity disorder (ADHD) is a
neurodevelopmental disorder with an estimated preva-
lence of 3–5% of the general population [1, 2]. Charac-
terised by inattention, hyperactivity and impulsivity [3],
ADHD significantly impacts on everyday functioning in
multiple domains, with knock-on effects on quality of
life [4]. Although ADHD is typically diagnosed, and its
treatment initiated, in middle childhood, prospective
longitudinal studies suggest that there are prodromal be-
havioural, cognitive and attentional markers prior to the
emergence of the full disorder, which in some cases are
evident at the age of 3 years [5]. Even in the early stages
the condition is associated with significant impairment
[6], but the problems often escalate as children grow,
giving rise to substantial difficulties in later life [7–9]. In
a recent prospective study it was estimated that high
levels of preschool ADHD symptoms were associated
with a 17-fold increase in economic burden to the men-
tal health, education and criminal justice systems by
early adulthood [10].
Typically initiated in middle childhood, a multimodal
combination of medication and psychological therapies
are recommended as treatment for ADHD on the basis
of the best available trial evidence [11]. However, evi-
dence of developmental continuity from early childhood,
and the potential for ADHD-related impairments to es-
calate over time, has prompted the development of early
intervention as an alternative treatment strategy [12].
Medication is not regarded as a viable early treatment
option in all but the severest cases – being less effica-
cious and associated with more adverse events when im-
plemented during the preschool period [13]. There is
strong resistance from many parents and clinicians to
the use of medication with preschool children. The most
frequently used nonpharamacological intervention for
preschool children with ADHD is parent training. In
parent training, parents are taught to modify their child’s
behaviour using techniques derived from social learning
theory principles [14]. However, trial data using blinded
outcomes suggests that parent training has only limited
effects on core ADHD symptoms, but it does have
other positive effects on children’s behaviour more
generally [15, 16].
Although not yet implemented as part of an early
intervention or prevention strategy, cognitive training
has recently been promoted as a treatment more gener-
ally for ADHD [17]. Cognitive training aims to exploit
the brain’s plasticity to improve the function of the brain
networks thought to mediate the risk for ADHD. It does
this through controlled exposures to cognitively de-
manding tasks over multiple training sessions [18]. To
date cognitive training approaches for ADHD have
targeted executive functions, including those affecting
attention, working memory and inhibitory control,
known to be impaired in a substantial proportion of
children with ADHD [18, 19]. Taken as a whole, results
from randomised controlled trials of cognitive training
for ADHD have been disappointing so far. Two recent
meta-analyses of randomised controlled trials [15, 18]
found that, as with parent training, reductions in ADHD
symptoms were not found on well-blinded outcomes. In
fact, for working memory training, the most studied ap-
proach, overall meta-analytic effects were close to zero
[18] despite promising initial findings [20].
While these results are disappointing, the logic under-
pinning cognitive training as a treatment for ADHD is
consistent with it being considered as a candidate for
early, or preventative, intervention. Indeed, it is possible
that the reason it has not worked so far is that it is being
implemented too late in development, when deficits are
already established and more resistant to change, while
at the same time brain plasticity is potentially decreas-
ing. Furthermore, there is evidence that atypicalities in
attention may develop very early on in individuals who
later develop symptoms of ADHD, i.e. during the first year
of life. In longitudinal studies, young children with greater
symptoms of inattention and hyperactivity at 3 years of age
have been shown to exhibit shorter eye-fixations on a
screen-based task [21], and shorter epochs of focussed at-
tention in a naturalistic context [22] during infancy. This
indicates continuities in the developmental pathway, from
executive attention skills in infancy, to emerging symptoms
of ADHD in the preschool years. Accordingly, it may be
crucial for cognitive training to be implemented as early as
is feasible during development – perhaps even prior to the
emergence of early signs of the disorder.
INTERSTAARS is a departure from previous cognitive
training approaches for ADHD as it represents the first
attempt to use cognitive training to target and
strengthen executive control networks in infancy with
individuals at risk, but not yet manifesting, the later de-
velopment of ADHD. The logic is that in infancy, when
neural plasticity is potentially greater and the brain is
more amenable to positive environmental effects, far-
transfer effects may be more likely [23]. Consistent with
this logic, a recent systematic review concluded that cogni-
tive training targeted at younger individuals led to signifi-
cantly more widespread transfer of training effects [23].
Previous research with typically developing infants
suggests that this age group is responsive to appropriate
cognitive training. Wass et al. [24] used a gaze-
contingent training paradigm to target attention control
in typical 11-month-old infants. Using eye-tracking tech-
nology, infants viewed animated games on a screen, and
the stimuli they were presented with in each of the
games changed adaptively, contingent on where on the
screen they were looking. The games were designed to
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target a number of aspects of executive attention includ-
ing sustained attention and inhibitory control. Following
four training sessions, infants showed training effects on
a battery of cognitive tasks when compared to an un-
trained, active control group [24].
In order to test the potential efficacy of cognitive
training as a preventative approach for ADHD, it is ne-
cessary to identify a group of infants who are at an in-
creased risk of developing the disorder. Fifty infants who
have a first-degree relative (either a parent or an older
sibling) with ADHD will take part in the INTERSTAARS
trial. The risk of ADHD is known to be familial, with el-
evated prevalence in individuals who have a parent or
sibling with the disorder. Sibling recurrence rates have
been documented to be between 12 and 35% [25–27],
and similar recurrence rates have been found between
parents and children [26].
Cognitive training for infants has previously been
tested in a laboratory setting [24]. However, administer-
ing the training in a research laboratory can be a burden
for families because they have to travel to the laboratory
for each training session. This burden may be particu-
larly large for at-risk families, such as families where a
parent or an older sibling also has ADHD. Therefore, to
optimise the acceptability of the intervention for fam-
ilies, the training programme will be carried out in fam-
ilies’ homes. The feasibility of implementing the training
games outside of a research laboratory has previously
been established in both community centre [28] and
school [29] settings.
The main objectives of the INTERSTAARS trial are to
test:
1. Whether a home-based attention control training
programme will improve attention control in infants
at familial risk of ADHD
2. Whether these effects are mediated by changes in
the executive attention system and will transfer to
changed attentional behaviours in a range of testing
contexts
3. Whether these changes in attention control are
associated with the amelioration of emerging ADHD
symptoms at 2 and 3 years of age
Methods/design
Study design and setting
INTERSTAARS is a two-site, double-blind, phase 2 ran-
domised controlled trial, involving clinicians and re-
searchers in London (Centre for Brain and Cognitive
Development, Birkbeck University of London and the
Institute of Psychiatry, Psychology and Neuroscience,
King’s College London) and Southampton (Department
of Psychology, University of Southampton), United
Kingdom. The trial is embedded within the Studying
Autism and ADHD Risks (STAARS) project at the
Centre for Brain and Cognitive Development (CBCD),
Birkbeck. STAARS is a longitudinal observational study
following infants from 5 months to 3 years of age, with
the aim of identifying early predictors of ADHD and aut-
ism spectrum disorder [30].
Eligibility and recruitment
Fifty 10–14-month old infants with a first-degree relative
(parent or older sibling) with a clinical or probable diag-
nosis of ADHD will take part in the INTERSTAARS
trial. Eligible families must: (1) live within a 2-h travel
distance from either London or Southampton, (2) have
at least one parent/caregiver who is fluent in English
and, (3) have agreed to take part in the affiliated
STAARS project. Participants will hear about the trial
via a variety of routes including: the National Health
Service (South London and Maudsley, and Solent
Trusts), recruitment databases at the University of
Southampton, Institute of Disorders of Impulse and
Attention (the South Hampshire ADHD Register and
the Programme for Early Detection and Intervention),
adult ADHD clinics, health visitors, community paedia-
tricians, ADHD support groups and charities. Posters
advertising the study will also be placed in local libraries,
cafes, children’s centres, general practitioner (GP) surger-
ies, play centres, nurseries and relevant online forums.
Where there is a suspected case of ADHD within a family
(parent or sibling) a formal assessment using age-
appropriate standardised screening questionnaires will be
used to establish the probable existence of ADHD1.
Exclusion criteria
Infants who meet any of the following criteria based on
parent-report will be excluded from the trial: (1) serious
medical or developmental conditions such as epilepsy,
heart conditions, cerebral palsy, intellectual disability,
(2) significant uncorrected vision or hearing problems,
(3) significant prematurity (less than 36 weeks’ gestation),
(4) genetic conditions such as Down’s syndrome or Fragile
X syndrome and (5) the eye-tracking technology used
throughout the trial cannot successfully track the infant’s
eyes after four attempts at the baseline assessment.
Participant timeline
Parents who express an interest in taking part in the trial
will be contacted by a research assistant at the relevant
trial site who will give them further information about
the study in person, over the phone or by email. All in-
terested families will be given at least a 24-h window in
which to consider their participation in the study. A
summary of the timeline for participants is shown in
Fig. 1. For families who agree to take part in the trial,
baseline and outcome assessments will be conducted
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both in the laboratory at the CBCD, Birkbeck, and in the
participant’s home. Baseline assessments will be con-
ducted when the infant is enrolled between 10 and
14 months of age (in the home and in the laboratory).
Outcome assessments will be conducted following the
intervention period, when the infant is 14–18 months of
age (in the home and in the laboratory). In addition, an
intermediate outcome assessment will be conducted
mid-way through the intervention period (home only).
Baseline and outcome assessments will include a series
of behavioural, neurophysiological, eye-tracking and
parent-report measures, all of which have been previ-
ously tested with infants (see ‘Outcomes’ below).
Parents’ written consent will be received at their first
visit to the CBCD before any baseline measures have
been collected. All costs incurred by participants’ visits
to the laboratory, e.g. travel and meals will be reim-
bursed. Participants will attend follow-up visits at the la-
boratory when they are 24 and 36 months of age. For
further details on the participant timeline, please refer to
the trial’s Consolidated Standards of Reporting Trials
(CONSORT) flow diagram [31] in Fig. 2.
Intervention
Infants allocated to the intervention group will receive
nine home-based attention training sessions, to be
carried out on a weekly basis. The attention training
programme uses gaze-contingent animations that oper-
ate via eye-tracking technology to target attention con-
trol. Infants view animated games on a computer screen
and where they look on the screen determines what they
see. Each training session involves two trained re-
searchers visiting the family’s home and setting up the
home-based eye-tracking equipment used to administer
the training. Data will be collected using a 60-Hz Tobii
X2-60 eye-tracker. Each training visit will last for ap-
proximately 1 h. During training sessions, the infant sits
on their parent’s lap, and the games are presented to
them on a Dell 19-inch monitor screen, with a screen
resolution of 1024 × 768. The games run using MATLAB
scripts, written by author SW and previously tested with
infants [24]. Games are intended to be attractive and en-
joyable for infants. The games are adaptive, so that as
the infant performs better, the levels increase and the
games become more challenging. The original training
programme [24] featured four games. In order to main-
tain engagement over the longer training phase planned
for INTERSTAARS (nine versus four training sessions),
additional versions of the original games have been
added to the training programme, closely based on those
used by Wass et al. [24] but with different surface fea-
tures. Together with one new game, they are designed to
train attention control across mixed cognitive domains
that include sustained attention, working memory, visual
search and inhibitory control. Five of the games are de-
scribed below. The other four games included in the
programme use the same training paradigm as one of
those described, but with new graphics and sound effects
to help maintain infant engagement.
Butterfly
In the Butterfly game, the infant is presented with a
cartoon butterfly on the computer screen. When the
infant fixates on the butterfly it flies across the
screen, from left to right. As it flies, various distrac-
tors (clouds, trees, houses) scroll from left to right. If
Fig. 1 Summary of participant timeline
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the child looks to any of the moving (and, therefore,
highly likely to be visually salient, [32]) distractors,
they disappear and only the butterfly remains on-
screen. The child has to learn that the only way to
progress on the task is to look to the butterfly and
inhibit the prepotent urge to look to distractors. The
salience of the distractors increases contingent with
performance, i.e. the better performing infants are
trained with more frequent and more salient distrac-
tors. Two of the other games included in the training
programme use the same training paradigm as Butterfly,
with new graphics and sound files.
Windows
In the Windows game, the infant is presented with two
windows on the left and right of the computer screen. A
cartoon earwig is presented in one window, together
with an attention-getter (a red circle) and an audio
sound effect to draw the infant’s attention to the earwig.
Once the child has looked to the earwig, it disappears,
and the infant is presented with a fixation point (a car-
toon flower) in the centre of the screen. When the infant
fixates on the flower it rotates until a delay period has
elapsed, and then disappears. If the infant then looks to
the correct window (where the earwig was previously
Fig. 2 Consolidated Standards of Reporting Trials (CONSORT) flow diagram
Goodwin et al. Trials  (2016) 17:608 Page 5 of 12
displayed) they receive a reward sequence showing the
earwig flying off the screen, accompanied by sound ef-
fects. As the infant progresses through the difficulty
levels, the delay period becomes longer and the number
of windows increases. Another game included in the
training programme uses the same training paradigm as
Windows, but with new graphics and sound files.
Stars
In the Stars game, the infant must search for the cor-
rect target within a complex visual scene. The target
(a cartoon character in a brightly coloured star) is
presented alongside eight distractors (e.g. planets,
clouds). The infant must look to the target within a
time limit. If they correctly locate the target they re-
ceive an animated reward sequence. As the infant
progresses successfully through trials, the levels be-
come more difficult by increasing the salience of the
distractors.
Suspects
In the Suspects game, a target (a colourful cartoon
elephant) is presented alongside a distractor. If the in-
fant fixates on the target elephant within a certain
time period then they receive a reward. A larger
number of distractors are presented contingent on
performance. Every 12 trials, the target switches:
where previously the child has received a reward for
looking to the elephant, they now start to receive a
reward for looking to a chicken. The target changes
periodically between the elephant and the chicken,
changing every 12 trials.
Puzzle Memory
In the Puzzle Memory game, a cartoon character is
presented in one of two locations. Following an ani-
mation, the character disappears and a fixation point
is presented elsewhere on the screen. If the child sub-
sequently looks back to the location where the char-
acter disappeared and maintains their gaze there, the
character reappears. A second character is then pre-
sented in the second location, followed by the same
sequence (character disappears, fixation point is pre-
sented). However, throughout this sequence, the pre-
viously found character remains on screen. During
the response window, the infant has to use the stored
memory to maintain their gaze on the location where
the new character has disappeared, and inhibit the
urge to look to the previously found character, which
is more immediately salient. At higher difficulty
levels, the number of locations increases. Another
game included in the training programme uses the
same training paradigm as Puzzle Memory but with
new graphics and sound files.
To ensure consistency of delivery between researchers
fixed rules have been developed for administering the
training games. Six training games are played per ses-
sion. Each training game is played for a maximum of
300 s, or until the infant becomes fidgety and has not
been engaged with the game for 20 s or more. The
MATLAB scripts are programmed to automatically rec-
ommend which game the researcher should play next dur-
ing a training session, according to an order that is
pseudorandomised across training visits. Cross-site quality
control meetings will be held to assess treatment delivery
at both sites using objective measures including: the dur-
ation of each training session, the number of games
played, the duration of each game played, and the percent-
age of eye-tracking data collected during each session.
The control arm
Infants in the control group will be allocated to a passive
viewing condition. The procedure for infants in the con-
trol group will be identical to those in the intervention
group, except that instead of viewing the attention train-
ing games during home visits they will view infant-
friendly, non-gaze-contingent television clips for an
equivalent amount of time. The set-up procedures, dur-
ation and audiovisual style of the clips will match the
intervention condition as closely as possible. For justifi-
cation of this control condition, please refer to the later
‘Discussion’ section.
The control condition runs using MATLAB scripts de-
veloped at the CBCD. Each control session involves two
trained researchers visiting the family’s home and setting
up the home-based eye-tracking equipment. Data will be
collected using a 60-Hz Tobii X2-60 eye-tracker. During
the session, the infant sits on their parent’s lap and the
television clips are presented to them on a Dell 19-inch
5:4 aspect-ratio monitor screen with a resolution of
1024 × 768. Each television clip is scaled to full screen,
with the aspect ratio maintained. Clips are played with
their original audio. Frame rates for the clips range from
23 to 30 frames per second (FPS). Individual clips from
the same television programme are combined into a
‘theme’. There are nine themes in total, similar to there
being nine training games in the intervention. The same
fixed rules used to deliver the intervention are also used
to administer the control condition. Six themes are
played per session. The MATLAB scripts automatically
recommend which theme the researcher should play
next, according to an order that is pseudorandomised
across sessions. Each theme is played for a maximum of
300 s, or until the infant becomes fidgety and has not
been engaged for 20 s or more. The same objective mea-
sures used to assess the delivery of the intervention, e.g.
session duration, number of themes played, will also be
collected for the control arm.
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Assignment of the intervention
Randomisation
Randomisation will be completed by a web-based ser-
vice, at the King’s Clinical Trial Unit (KCTU, [33]). Ran-
domisation will be done on an individual level,
minimising by trial site (London or Southampton) and
gender of the infant (male or female). Allocation is per-
formed when a trained, unblinded researcher logs into
the KCTU system, and the system then sends an auto-
matic email to the researcher confirming the allocation
of the participant. This procedure will be performed
after the baseline assessments have been completed, be-
fore the first attention training/control session.
Blinding
Researchers who administer the baseline and outcome
assessments will be blind to treatment condition. Efforts
will be made to ensure that parents are also blind to
treatment condition. To maintain parent blindness
throughout the trial the number of home visits, contact
with trainers, and set-up procedures will be identical be-
tween the intervention and control groups. At the end
of the trial, a qualitative interview will be conducted
with the primary parent/caregiver to assess whether they
have remained blind to treatment condition throughout
the intervention period. Due to the nature of the inter-
vention, it will not be possible for the researchers who
administer the attention training to remain blind to the
treatment condition. However, the treatment and control
conditions are run using automated MATLAB scripts
and data metrics from these tasks will be analysed by
different, blinded researchers. The researchers who ad-
minister the intervention will not be involved in the col-
lection of outcome data. The only exception to this will
be the intermediate outcome assessment. Researchers
who conduct the intermediate outcome assessment will
not be blind to treatment condition. To note, data from
the intermediate assessment is not included as any of
the primary or secondary outcomes.
Adherence and fidelity
Adherence to the trial will be judged to exist as a mini-
mum of six training/control sessions per infant, with a
minimum average session duration of seven min. Fidelity
will be measured as the percentage of eye-tracking data
collected across training/control sessions (i.e. the amount
of time the infant was looking towards the screen and the
eye-tracker was detecting their gaze).
Outcomes
A summary of all measures collected in the trial can be
found in Additional file 1: Table S1. Data for the primary
and secondary outcomes will be collected before and
after the intervention period, both in the laboratory and
in the home. The infant’s parent will be present for all
measures collected during these assessments. Parents
are asked to respond to their infant’s needs but not to
actively initiate interaction with their infant or try to dir-
ect their attention. Visits to the laboratory take approxi-
mately 5 h. Parents will be reminded at the start of each
session that they can ask to stop or take a break at any
time for any reason. All infant assessments will be video-
taped whenever feasible.
Primary outcome
The primary outcome in the trial will be a composite of
eye-tracking measures used to assess changes in infant
attention control. This eye-tracking data will be col-
lected in the home, using a 20-min eye-tracking battery
designed to measure different aspects of infant attention.
The tasks included in the battery are the: cognitive con-
trol task, sustained-attention task, sequence learning
task, distractor task, visual paired comparison task, and
gap-overlap task (see Table 1 for a description of each
task). From this battery, three eye-tracking measures
were selected for the primary outcome composite, based
on their responsiveness to attention training in previous
replications of the intervention [24]:
1. Sustained attention (an infant’s ability to maintain
their attention on a stimulus). This will be measured
as the peak duration of infant looking time towards
a series of interesting static stimuli in the sustained-
attention task. Peak look duration is defined as the
longest of the first five individual looks towards each
stimulus
2. Disengagement effect (an infant’s ability to disengage
their attention from a stimulus). This will be
measured as the difference between mean saccadic
reaction times between the baseline and overlap
conditions in the gap-overlap task
3. Cognitive control (an infant’s ability to learn a rule,
and later inhibit this information to shift attention to
a new rule). This will be measured as the percentage
of trials in which infants correctly anticipate the
location of the target stimuli in the pre- and post-
switch phases of the cognitive control task.
Secondary outcomes
Secondary outcomes were selected to assess whether
changes in infant attention control following attention
training transfer to more naturalistic contexts. The fol-
lowing measures will be secondary outcomes in the trial:
1. Parent-report measures of infant executive attention
assessed by the Infant Behavior Questionnaire-
Revised [34], including the effortful control, activity
level and duration of orienting scales
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2. Observational measures of infant attention to toys
during toy play including the task orientation
episode from the Laboratory Temperament
Assessment Battery, Lab-TAB [35], and a structured
free-play episode adapted from [36]. Behavioural
coding will be completed using an in-house coding
scheme and the Lab-TAB manual
3. Observational measures of infant social attention
skills using the Early Social Communication Scales
(ESCS) [37]. The following ESCS tasks will be
administered: responding to the joint attention task,
the social interaction task, the initiating joint attention
task, and the book-reading task. Infant behaviours will
be coded according to the ESCS manual
4. General attentiveness as measured by infant average
look duration to the stimulus presentation area
across the entire 20-min eye-tracking battery
ADHD symptom trajectories
Follow-up visits to the laboratory will be completed at 2
and 3 years of age. At age 3, standardised measures will
be used to assess the presence of early ADHD symptoms
including the Child Behaviour Checklist [38], the young
child Diagnostic Interview Schedule for Children [39],
and the teacher and parent-report Conners’ Early
Childhood [40], as well as measures of executive func-
tion (the Behavioural Rating Inventory of Executive
Functions [41]).
Data collection and management
Sample size and power
Wass et al. [24] found an effect size of 0.69 on the cogni-
tive control task following the attention training interven-
tion in a sample of typically developing infants. Based on
this effect, a sample of 50 participants (25 in each condi-
tion) is required to allow for sufficient power. This sample
size will allow for 10% attrition (n1 = 22, n2 = 23), with
82% power and a two-tailed significance value of 0.05,
using an analysis of covariance (ANCOVA) with baseline-
outcome correlation of 0.6 (Stata 14 sampsi,) [42].
Data management
Parent-report measures will be stored using a secure on-
line database called REDCap (Research Electronic Data
Table 1 Summary of eye-tracking battery
Task Summary
Cognitive control adapted from [24, 49] At the beginning of each trial, the infant is presented with a fixation point in the centre of the screen.
Once the infant looks to the fixation point, an audio reward is presented, followed by a visual reward
(a short animated clip), which is presented on either the left or right of the screen. The visual reward
is presented on 1 side for 9 consecutive trials (pre-switch) before switching to the other side for the
subsequent 9 trials (post-switch). Anticipatory saccades are coded based on the child’s looking
behaviour during the anticipatory window (between the start of the auditory reward and the start of
the visual reward). The dependent variable is the percentage of trials in which infants make a correct
anticipatory saccade towards the location of the target stimuli in the pre- and post-switch phases.
Sustained attention adapted from [24] The infant is presented with two ‘interesting’ (complex, detailed) and two ‘boring’ (noncomplex) static
stimuli. For each stimulus, the experimenter records the length of the first 5 of the infant’s looks
towards the stimulus presentation area. To qualify as a look the infant must visually engage with the
stimulus for at least 1 s. To terminate the look, the infant must disengage from the stimulus for at
least 1 s. The longest of the first 5 looks is termed the peak look duration. The dependent variable is
the peak look duration towards the interesting stimuli.
Gap-overlap adapted from [47, 50] The infant is presented with a stimulus in the centre of the screen. Once the infant fixates on this
central stimulus, a peripheral stimulus appears on the left or right of the screen. When the infant
moves their gaze from the central to the peripheral stimulus they receive an audiovisual reward.
There are three conditions in this task: baseline, overlap and gap. In the baseline condition, the central
stimulus disappears at the same time that the peripheral stimulus appears. In the gap condition, there
is a 200-ms gap between the removal of the central stimulus and the appearance of the peripheral
stimulus. In the overlap condition, the central stimulus remains on the screen after the peripheral
stimulus appears. The dependent variable is the saccadic reaction time (ms) to move the eyes from
the central to the peripheral stimulus in the overlap condition.
Sequence learning adapted from [51] The infant is presented with a target cartoon character (e.g. a bunny rabbit) that can appear in one of
6 locations. If the infant moves their gaze to the correct target location prior to the emergence of the
cartoon character then they receive an audiovisual reward. For the first 8 trials, the character appears
in a sequence of locations 1, 3, 5. After 8 trials the sequence reverses. The dependent variable is the
proportion of correct anticipatory saccades towards the target location.
Visual paired comparison adapted from [52] The infant is presented with a static image (Image A) in the centre of the screen. Image A is presented
until the infant has looked at it for a total of 10 s. Following this 10-s period, Image A is presented
alongside a new image, Image B. The dependent variable is the infant’s look duration towards the
new versus the familiar stimulus.
Distractor adapted from [53] An animated cartoon is presented in the centre of the screen. Throughout its presentation, distractors
randomly appear on the left or right side of the screen. If the infant looks towards the distractors then
the cartoon is paused. The dependent variable is the number of looks towards the distractors.
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Capture) [43]. To ensure blinding, only unblinded re-
searchers will have access to the INTERSTAARS
REDCap database. A subset of data (10%) will be double
entered into REDCap to assess reliability of data entry
across researchers. Experimental data (e.g. eye-tracking
and neurophysiological measures) will be stored on a se-
cure server at the CBCD.
Statistical methods
An intention-to-treat (ITT) approach will be used to
analyse data from the trial, which will follow a Statistical
Analysis Plan specified prior to data inspection, ap-
proved by the Data Monitoring and Ethics Committee,
with analyses undertaken with uninformative treatment
group labels. The primary outcome measure will be a
composite of the three eye-tracking components selected
above in ‘Outcomes’. The three components will be ana-
lysed together initially for evidence of a common treat-
ment effect, equivalent to a treatment effect for the
simple sum of normalized standardized scores of each
component. A multivariate ANCOVA will then be used
to test the treatment effect of the attention training group
compared to the control group, using Stata sem [42].
Missing data
Missing baseline and outcome data will be treated as ig-
norable under the assumption of missing-at-random.
This assumption can be made due to the repeated mea-
sures set-up in which both baseline and outcome vari-
ables are treated as dependent variables with all valid
scores for each component included.
Sensitivity analysis
If more than 10% of participants are missing compo-
nents of the primary outcome then a sensitivity analysis
will be performed. This analysis will be completed using
Stata mi.
Ethical issues
Ethical approval
Ethical approval has been granted for the trial from the
National Health Service Integrated Research Application
Service, London Central Research Ethics Committee
(Reference: 15/LO/0407).
Data monitoring
The Data Monitoring and Ethics Committee will meet
biannually to discuss the INTERSTAARS trial. To moni-
tor for possible adverse side effects of participating in
INTERSTAARS, the following information will be col-
lected regularly throughout the trial:
1. Infant sleep: we will use a Sleep Diary (developed by
our own laboratory) to measure infant sleeping
patterns. Data collected includes the amount of
sleep during the day and during the night, and the
number of times the infant wakes during the night.
The Sleep Diary will be completed for the night
before, and the night following, each attention
training or control session
2. Infant fussiness: we will use a Fussiness Scale
(developed by our own laboratory) to measure infant
fussiness. Fussiness will be rated on a 1 to 5 scale for
the 4 h following each attention training or control
session, and for the 4 h that is comparable from the
previous day, i.e. if a training session finishes at
2 p.m., fussiness will be rated from 2 p.m. to 6 p.m.
for that day, and from 2 p.m. to 6 p.m. for the
previous day.
3. The Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) checklist [44] for this
manuscript is included as Additional file 2.
Funding
The INTERSTAARS trial is funded by the charity MQ:
Transforming Mental Health. Funding for follow-up
visits for the study at 24 and 36 months of age is from
the Medical Research Council (MRC), which funds the
STAARS programme into which the INTERSTAARS
trial is integrated.
Discussion
INTERSTAARS is a two-site randomised controlled trial
investigating the potential efficacy of nine weekly atten-
tion training sessions to improve attention control in in-
fants at familial risk of ADHD. The trial is novel;
cognitive training has not previously been applied to in-
fants at increased risk of developing attention problems.
While early psychological interventions have been cham-
pioned as a way of reducing the risk for ADHD, studies
have so far focussed on young children already display-
ing ADHD symptoms. Through its implementation in
infancy, before symptoms have emerged, INTER-
STAARS offers a potential preventative approach for
infants at heightened risk. The intervention is home-
based, making it a viable option for at-risk families.
Results from the INTERSTAARS trial will make a
novel contribution to research on early interventions for
ADHD, and will help to further our understanding of in-
fant attention in general.
While the trial will greatly contribute to these fields of
research, potential limitations of the study should also
be recognised. One difficulty encountered in the design
of the trial was selecting an appropriate control condi-
tion. There were several options for control participants
including: (1) treatment as usual, (2) a yoked control de-
sign and (3) a passive viewing condition. Treatment as
usual was not selected because we wanted to ensure that
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differences between the control condition and the treat-
ment condition were specific to attention training, and
were not the result of another aspect of home visits,
such as frequent interaction with researchers, or the
amount of screen time. Furthermore, as INTERSTAARS
targets an at-risk cohort (rather than a population
already diagnosed, or exhibiting, ADHD symptoms) it is
unlikely that the infants involved in the trial would have
been previously receiving any form of intervention for
ADHD prior to entering the trial.
In the second option for the control condition, a yoked
control design, participants would view the attention
training games, but the games would not be gaze-
contingent. This condition appeared optimal in minimis-
ing the differences between the two conditions. How-
ever, pilot studies by SW showed that infants became
bored quickly when watching the yoked control condi-
tion, making it difficult to match the conditions on over-
all screen time, so this condition was also not selected.
Instead, a passive viewing condition was used. This is
the same control condition used in previous studies with
this attention training intervention [24, 28]. It allows for
the conditions to be matched on screen time. However,
the surface audiovisual features of what the infants view
on the screen will differ between conditions.
There are also some limitations associated with using
a familial risk group as the sample for the trial. Using a
prospective design allows researchers to target a group
of individuals who are at an increased risk of developing
the disorder of interest, and to study this group in depth
as they develop through infancy and beyond [45, 46].
Fifty infants at familial risk of ADHD will be recruited to
the trial, a sample size that is modest enough to assess
group differences following attention control training.
However, it should be noted that not all of the infants
included in the trial would develop ADHD without
intervention. To generalise any findings to infer that at-
tention control training leads to reduced ADHD recur-
rence will not be possible within this early stage trial. If
significant group effects are found for attention control
training in the INTERSTAARS sample then it will be
important to test this approach with larger groups of in-
fants in the future.
In addition to using larger samples, future research
should also investigate the potential efficacy of attention
training with other risk groups. ADHD is a heteroge-
neous disorder, in that different subgroups of the
population may enter the disorder via different devel-
opmental pathways [47]. While the results of the
INTERSTAARS trial will be relevant for infants at in-
creased familial risk of ADHD, whether the results
are also applicable to other groups of infants at risk
of ADHD, e.g. premature infants [45], will require
further investigation. If successful across ADHD risk
groups, future research could investigate the impact
of attention training on generic attention control
skills, for individuals in the general population with
subclinical markers of low attention control during
infancy or for other developmental disorders that ex-
hibit impaired attention control. This would be ap-
plicable to numerous other risk groups, including
infants at risk of autism spectrum disorder [48]. The
home-based nature of the intervention allows for it to
be feasibly administered to high-risk populations who
might otherwise be difficult to reach.
Trial status
The first participant was enrolled and randomised in
November 2015. Recruitment is ongoing.
Endnotes
1Standardised questionnaires will be administered over
the phone with the parent by a trained researcher. For
siblings < 6 years of age, a shortened version of the Con-
ners Early Childhood [40] will be administered. For sib-
lings >= 6 years of age, a shortened version of the
Conners 3 [54] will be administered. Cut offs for inclu-
sion will be the presence of 4 (Conners Early Childhood)
or 5 (Conners 3) DSM-5 ADHD symptoms on either the
hyperactivity/impulsivity or inattention scale, and a posi-
tive score on the impairment scale. For parents, a short-
ened version of the Conners Adults ADHD Rating Scale
(CAARS) [55] will be administered. Cut offs for inclu-
sion using the CAARS will be the presence of 5 DSM-5
ADHD symptoms on either the hyperactivity/impulsivity
or inattention scale.
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